|
Deficient Lung Function
Graham Johns, the son of the Managing Director of Chemcept Limited died of lung
failure whilst on a lung-transplant waiting list. We have now reached the
position that the majority of people on such lists die before transplant. As a
Chemical and Bio-Chemical Engineer, Dr Johns has been motivated to seek a path
to minimize such future tragedies. Accordingly, we have developed and patented
new devices to aid, or replace, lung function. We have a commitment from a
leading Welsh university, with relevant expertise, to develop the device for
clinical use. Further details can be found on the web site:
http://www.haemair.com
Chemcept Ltd., Crays Pond, Reading, England
|